Meridian Bioscience to Participate in H. C. Wainright Bioconnect 2021 Virtual Conference
January 06 2021 - 9:30AM
Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic
testing solutions and life science raw materials, announced today
its participation in the H. C. Wainright Bioconnect 2021 Virtual
Conference. Jack Kenny, Chief Executive Officer, will pre-record a
fireside chat that will be available on January 11, 2021.
Jack Kenny will also be participating in a panel
discussion hosted by former FDA Commissioner Scott Gottlieb, M.D.
on Tuesday, January 12, 2021 from 12:00pm to 1:00pm Eastern Time.
The panel is entitled “FDA Regulation (Diagnostics and Devices,
Potential Changes to Come).” Panel participants also include Dwight
Egan, President & CEO of Co-Diagnostics, Michael Nall,
President & CEO of Biocept, Inc., and Dr. Reginald Seeto,
President and CEO of CareDx, Inc.
Webcast links to Meridian’s fireside chat and
the panel discussion will be available in the Events &
Presentations section of the Company’s Investor Relations website
at https://investor.meridianbioscience.com/. The fireside chat will
be available for 90 days and the panel discussion will only be
available live.
For additional information on the H. C.
Wainright Bioconnect 2021 Virtual Conference, please visit
www.hcwevents.com/bioconnect.
About Meridian Bioscience,
Inc.Meridian is a fully integrated life science company
that develops, manufactures, markets and distributes a broad range
of innovative diagnostic products. We are dedicated to developing
and delivering better solutions that give answers with speed,
accuracy and simplicity that are redefining the possibilities of
life from discovery to diagnosis. Through discovery and
development, we provide critical life science raw materials used in
immunological and molecular tests for human, animal, plant, and
environmental applications. Through diagnosis, we provide
diagnostic solutions in areas including gastrointestinal and upper
respiratory infections and blood lead level testing. We build
relationships and provide solutions to hospitals, reference
laboratories, research centers, veterinary testing centers,
physician offices, diagnostics manufacturers, and biotech companies
in more than 70 countries around the world.
Meridian’s shares are traded on the NASDAQ
Global Select Market, symbol VIVO. Meridian’s website address is
www.meridianbioscience.com.
Contact:Charlie WoodVice President – Investor
RelationsMeridian Bioscience, Inc.Phone: +1 513.271.3700Email:
mbi@meridianbioscience.com
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Meridian Bioscience (NASDAQ:VIVO)
Historical Stock Chart
From Sep 2023 to Sep 2024